Volume 6, Issue 6, December 2020, Page: 116-119
Prediabetes & Diabetes Among Patients with Axial Spondyloarthritis
Abu Tahir Muhammad Tanveer Hasan, Department of Rheumatology, Enam Medical College & Hospital, Dhaka, Bangladesh
Muhammad Abdul Alim, Department of Medicine, MH Samorita Hospital and Medical College, Dhaka, Bangladesh
Received: Oct. 17, 2020;       Accepted: Nov. 2, 2020;       Published: Nov. 9, 2020
DOI: 10.11648/j.ejcbs.20200606.11      View  25      Downloads  6
Abstract
Background & Objectives: There is an increased risk of cardiovascular diseases among patients with spondyloarthritis. Coexisting diabetes mellitus can potentially add to the risk. The objective of this study was to determine the frequency of glucose intolerance in patients with spondyloarthritis. Materials & Methods: The study was conducted among 85 participants with axial spondyloarthritis who visited the Department of Rheumatology, Enam Medical College & Hospital, Savar, Dhaka, Bangladesh from September, 2018 to December, 2019. The participants underwent either oral glucose tolerance test or estimation of HbA1C. Results: The mean age of participants was 40.6 years. The majority (57.6%) of them belonged to the young age group (18-40 years). 30.6% of the participants were prediabetic. Diabetes mellitus was found to be present in 20% of the participants. There was no significant difference between the study population and the general population in terms of frequency of prediabetes. But the frequency of diabetes in the study population was higher than that in the general population. There was no significant difference between males and females with regard to the frequencies of prediabetes and DM. Diabetes mellitus was more common in the elderly age group. Conclusion: Considering the greater burden of DM among patients with axial spondyloarthritis, routine screening for DM may be indicated in these individuals.
Keywords
Axial Spondyloarthritis, Prediabetes, Diabetes Mellitus
To cite this article
Abu Tahir Muhammad Tanveer Hasan, Muhammad Abdul Alim, Prediabetes & Diabetes Among Patients with Axial Spondyloarthritis, European Journal of Clinical and Biomedical Sciences. Vol. 6, No. 6, 2020, pp. 116-119. doi: 10.11648/j.ejcbs.20200606.11
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Yu DT, van Tubergen A. Overview of the clinical manifestations and classification of spondyloarthritis. Up To Date. Sieper J, Romain PL, ed. Up To Date. Maltham, MA: Up To Date Inc. Available from: (Updated 7 September 2018, cited 17 December 2019).
[2]
Ahmed S, Haq SA, Al-qadir AZ, Rahman MM, Paul S. Survey on prevalence of rheumatic disorders in Bangladeshi adults. Ann Rheum Dis. 2017; 76 (2): 1044-1045.
[3]
Zeidler H, Amor B. The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress. Ann Rheum Dis 2011; 70: 1.
[4]
Zeidler H, Calin A, Amor B. A historical perspective of the spondyloarthritis. Curr Opin Rheumatol 2011; 23: 327.
[5]
de Winter JJ, van Mens LJ, van der Heijde D, LandewéR, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016; 18: 196.
[6]
Essers I, Stolwijk C, Boonen A, De Bruin ML, Bazelier MT, de Vries F, van Tubergen A. Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis. 2016; 75 (1): 203.
[7]
Mathieu S, Soubrier M. Cardiovascular events in ankylosing spondylitis: a 2018 meta-analysis. Annals of the Rheumatic Diseases. 2019; 78 (6): e57.
[8]
Tam LS, Shang Q, Li EK, Tomlinson B, Chu TT, Li M, Leung YY, Kwok LW, Wong KC, Li TK, Yu T. Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Care & Research: Official Journal of the American College of Rheumatology. 2008; 59 (9): 1322-31.
[9]
Jamnitski A, Symmons D, Peters MJ, Sattar N, MciInnes I, Nurmohamed MT. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Annals of the rheumatic diseases. 2013 Feb 1; 72 (2): 211-6.
[10]
Eder L, Chandran V, Cook R, Gladman DD. The risk of developing diabetes mellitus in patients with psoriatic arthritis: a cohort study. The Journal of rheumatology. 2017 Mar 1; 44 (3): 286-91.
[11]
World Health Organization. International Diabetes Federation (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. IDF consultation. 2008.
[12]
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care. 2019 Jan 1; 42 (Supplement 1): S13-28.
[13]
Akter S, Rahman MM, Abe SK, Sultana P. Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey. Bulletin of the World Health Organization. 2014 Jan 10; 92: 204-13A.
[14]
Aguiree F, Brown A, Cho N, Dahlquist G, Cho D, Dodd D. Whiting (2013) IDF Diabetes Atlas. IDF Diabetes Atlas, 6th Edition, International Diabetes Federation, Basel. 2013; 74-90.
[15]
Islam SM, Purnat TD, Phuong NT, Mwingira U, Schacht K, Fröschl G. Non-Communicable Diseases (NCDs) in developing countries: a symposium report. Globalization and health. 2014 Dec; 10 (1): 81.
[16]
Chen HH, Yeh SY, Chen HY, Lin CL, Sung FC, Kao CH. Ankylosing spondylitis and other inflammatory spondyloarthritis increase the risk of developing type 2 diabetes in an Asian population. Rheumatology international. 2014 Feb 1; 34 (2): 265-70.
[17]
Liao K, Kuo Y, Lai S. Diabetes mellitus in ankylosing spondylitis. Annals of the Rheumatic Diseases Published Online First: 06 September 2019.
[18]
Hmamouchi I, Bahiri R, Hajjaj-Hassouni N. Clinical and radiological presentations of late-onset spondyloarthritis. ISRN rheumatology. 2011; 2011: 840475.
[19]
Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Annals of the rheumatic diseases. 2020 Jan 1; 79 (1): 39-52.
[20]
Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian journal of endocrinology and metabolism. 2012 Mar; 16 (Suppl1): S27.
[21]
Gregg EW, Li Y, Wang J, Rios Burrows N, Ali MK, Rolka D, Williams DE, Geiss L. Changes in diabetes-related complications in the United States, 1990–2010. New England Journal of Medicine. 2014 Apr 17; 370 (16): 1514-23.
Browse journals by subject